AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Artemis Alpha Trust PLC

Fund Information / Factsheet Jul 25, 2018

4779_rns_2018-07-25_94054f50-27c2-40ef-b632-c4cd42f588a3.html

Fund Information / Factsheet

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7591V

Artemis Alpha Trust PLC

25 July 2018

ARTEMIS ALPHA TRUST PLC  (the "Company")

Sale of Unlisted Equity Investment

The Company is pleased to note the announcement from Stamps.com  which has entered into a definitive agreement to acquire the total shares outstanding of Metapack Ltd., an unlisted equity representing 3.1% of the Company's NAV, for cash. 

The agreed sale price represents a 24.8% uplift to current carrying value. Total proceeds of £6.5m represent a 5.4x return on the investment. The positive impact on the Company's NAV will be 0.8% with adjustment taking place upon the transaction becoming wholly unconditional, expected to be between the 15th and 28th of August. 

The Company also notes that the sale of its unlisted holding in Oxford Sciences Innovation was completed earlier in the month at carrying value, representing 1.3% of NAV. Following the completion of the sale of Metapack, the Company's pro-forma exposure to unlisted equities will be 12.1%.

For further information, please contact:

Artemis Fund Managers Limited

Company Secretary

Telephone: 0131 225 7300

25 July 2018

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCUVVURWRABUAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.